Alimera Sciences Inc (ALIM)

10.30 -0.08  -0.77% NASDAQ Jun 11, 20:00 USD
View Full Chart
Price Chart
View All ALIM News

News

View All Events

Events

Date Type Description
07/30/2021 09:00 EST Earnings Calls Q2 2021 Earnings Call
07/29/2021 Earnings Results Q2 2021 Earnings Results
04/29/2021 09:00 EST Earnings Calls Q1 2021 Earnings Call
04/28/2021 Earnings Results Q1 2021 Earnings Results
02/25/2021 09:00 EST Earnings Calls Q4 2020 Earnings Call
02/24/2021 Earnings Results Q4 2020 Earnings Results
10/29/2020 09:00 EST Earnings Calls Q3 2020 Earnings Call
10/28/2020 Earnings Results Q3 2020 Earnings Results
07/30/2020 09:00 EST Earnings Calls Q2 2020 Earnings Call
07/29/2020 Earnings Results Q2 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Alimera Sciences Inc is a pharmaceutical company focused on commercializing and developing treatments that address diseases affecting the back of the eye (retina). ILUVIEN is Alimera's a patented micro-implant which delivers a continuous, low dose anti-inflammatory agent to the retina for up to 3 years. DME is often treated with acute therapies when the fluid in the eye returns. ILUVIEN reduces the recurrence of edema to stable vision, with the benefit of continuous treatment due to the product's novel drug delivery technology. The company expects to accelerate growth of ILUVIEN through increased penetration of existing markets; expansion into new markets; and a new indication for non-infectious posterior uveitis in the EU.
  • URL: https://www.alimerasciences.com
  • Investor Relations URL: http://investor.alimerasciences.com/index.cfm
  • HQ State/Province: Georgia
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Jul. 29, 2021
  • Last Earnings Release: Apr. 28, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.